Spouting Rock Asset Management, LLC Recursion Pharmaceuticals, Inc. Transaction History

Spouting Rock Asset Management, LLC

  • $273 Million
  • Q4 2023

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022
SELL
$6.16 - $18.03 $555,650 - $1.63 Million
-90,203 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$16.14 - $21.86 $602,861 - $816,514
37,352 Added 70.67%
90,203 $1.55 Million
Q3 2021

Nov 15, 2021
BUY
$19.03 - $41.33 $1.01 Million - $2.18 Million
52,851 New
52,851 $1.22 Million

Others Institutions Holding RXRX

# of Institutions
371
Shares Held
290M
Call Options Held
7.75M
Put Options Held
6.1M
View Full List

About RECURSION PHARMACEUTICALS, INC.

RXRX Quotes by TradingView
  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $902M
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Spouting Rock Asset Management, LLC Portfolio

Follow Spouting Rock Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Spouting Rock Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Spouting Rock Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email